🇺🇸 FDA
Patent

US 12298319

Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulators

granted A61KA61K45/06A61P

Quick answer

US patent 12298319 (Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulators) held by Takeda Pharmaceutical Company Limited expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K45/06, A61P, A61P25/28